Health
Results: 385-396 of 10101

Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

UK digital pathology provider Source BioScience chooses Sectra to enable seamless pathology collaboration across the NHS

C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer's Trust to Improve Alzheimer's Disease Diagnosis

Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies



